1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders

Details for Australian Patent Application No. 2005275036 (hide)

Owner Amgen Inc.

Inventors Yang, Kevin; Human, Jason Brooks; Aya, Toshihiro; Han, Nianhe; Qian, Wenyuan; Peterkin, Tanya; Askew, Jr. Benny C.; D'Amico, Derin C.; Yuan, Chester Chenguang; Chen, Jian Jeffrey; Nguyen, Thomas; Cai, Guolin; Zhu, Jiawang; Nishimura, Nobuko; Huang, Qi; Biswas, Kaustav; Liu, Qingyian; Nomak, Rana

Agent Shelston IP

Pub. Number AU-A-2005275036

PCT Pub. Number WO2006/019975

Priority 60/588,904 15.07.04 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

International Classifications

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019975 Priority application(s): WO2006/019975

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275050-Reference equipment for testing contactless payment devices

2005275033-Suppression of the formation of noxious substances during chloride processes